REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Share News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Phorm Corp Makes Progress On Fundraising Efforts (ALLISS)

Thu, 04th Feb 2016 18:25

LONDON (Alliance News) - Phorm Corp PLC on Thursday said it is yet to receive the money needed to settle a USD1.0 million equity subscription agreed with a US-based institutional investor, though it has received funds from FiveT Investment Management Ltd and Arminius Verwaltung AG under separate deals.

The advertising company said it has received a total of USD500,000 from FiveT and Arminius, with the provision of the funds evenly split between them. FiveT and Arminius have each been transferred 14.6 million shares, a figure which takes into account a loan conversion after receiving notices from Michael Bigger and Arminius for repayment.

FiveT is a company associated with Johannes Minho Roth, a non-executive director of Phorm. Roth is the founding director, chief executive officer and majority shareholder of FiveT's parent company, FiveT Capital Holding AG.

The company has received also USD250,000 through the draw down of the first tranche of a loan agreed with Meditor, a major shareholder in Phorm with just shy of a 23% stake. Meditor has agreed to provide up to USD2.75 million in total spread across three tranches.

Thanks to the completion of the subscription with FiveT and Arminius, Phorm has asked to draw down the next USD250,000 tranche.

Under the terms of the loan, the draw down of the first tranche resulted in an arrangement fee of 4.0 million new shares, which will now be issued to Meditor. A similar arrangement stands with regards to the second tranche.

Phorm is required to secure further equity funding of at least GBP2.5 million, at a price at or around its share price, by February 24 if it is to be able to draw down of the third and final USD2.25 million tranche of the loan.

Meanwhile, the US-based institution with which Phorm agreed a USD1.0 million equity subscription last month has failed to transfer the required funds to settle the deal under their legally binding agreement. Phorm said it is continuing to take legal advice over the matter.

Shares in Phorm closed down 12% at 1.10 pence on Thursday,

By Samuel Agini; samagini@alliancenews.com; @samuelagini

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
14 Apr 2016 15:36

Phorm finally fizzles out, leaving shareholders with nought

(ShareCast News) - Phorm's controversial time on the stock market stumbled toward an ignominious end on Thursday as the notorious money-pit failed to find further funding, its nominated adviser Strand Hanson threw in the towel and a winding-up process began. Long-suffering shareholders, including th

Read more
14 Apr 2016 09:15

Phorm Ceasing Activities, Nomad Resigns As It Fails To Secure Funding

Read more
16 Mar 2016 16:00

Suspended Phorm raises fresh capital through note issue

(ShareCast News) - Advertising technology company Phorm had £350,000 more cash in its pocket on Wednesday, after issuing convertible loan notes in the amount to existing shareholder Michael Bigger. In accordance with the terms of the convertible loan note instrument, interest would accrue on the uns

Read more
25 Feb 2016 09:35

Phorm Shares Suspended As It Fails To Secure Final Funding Tranche (ALLISS)

Read more
1 Feb 2016 16:32

Phorm In Flurry Of Financing Arrangements To Secure Future (ALLISS)

Read more
21 Jan 2016 09:40

Phorm Secures TRUSTe Data Collection Privacy Certfication

Read more
18 Jan 2016 09:45

Phorm Corp Raises USD1 Million As It Tries To Cut Cash Burn Rate (ALLISS)

Read more
6 Nov 2015 09:37

Phorm Raises GBP2.1 Million For General Working Capital (ALLISS)

Read more
28 Oct 2015 07:57

Phorm Corp Teams Up With INSOMNIS Media To Improve Campaigns

Read more
20 Oct 2015 09:16

Phorm selected to help Causemo profile potential donors

(ShareCast News) - Phorm has teamed up with Causemo to improve the identification of and personalised communication with potential donors online. The AIM listed advertising-technology company announced the deal on Tuesday with the US charitable causes donation market innovator. It will use Phorm's

Read more
20 Oct 2015 06:46

Phorm Inks Deal With Boston-Based Fundraising Firm Causemo

Read more
13 Oct 2015 09:14

Phorm appoints new chief revenue officer

(ShareCast News) - Phorm Corporation has hired David Paquette as the company's new chief revenue officer. The appointment, announced Tuesday, is expected to "cultivate and accelerate sales of the company's technology platform, particularly in the US". Paquette brings 15 years of sales experience in

Read more
13 Oct 2015 07:11

Phorm Appoints David Paquette As Chief Revenue Officer

Read more
9 Oct 2015 09:41

Boston Globe to implement Phorm's ad technology

(ShareCast News) - Phorm Corporation has signed a deal for Boston Globe Media Group to use its advertising technology on the media group's digital properties. The company announced the deal on Friday, which will use its Machine-Learning Artificial Intelligence technology to identify and target speci

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.